510(k) K113181

CELLTRACKS ANALYER II by Veridex, LLC — Product Code NQI

K113181 is an FDA 510(k) premarket notification submitted by Veridex, LLC for the device "CELLTRACKS ANALYER II". The FDA issued a decision of Substantially Equivalent on Dec 12, 2011. The device falls under product code NQI (System, Immunomagnetic, Circulating Cancer Cell, Enumeration), a Class II device regulated under 21 CFR 866.6020. Veridex, LLC has 11 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Dec 12, 2011
Date Received
Oct 28, 2011
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device classification

Device Name
System, Immunomagnetic, Circulating Cancer Cell, Enumeration
Device Class
Class II
Regulation Number
866.6020
Review Panel
PA
Submission Type
510(k)

In vitro diagnostic device to aid in the enumeration of immunomagnetically selected and fluorescently identified circulating tumor cells of epithelial origin in whole blood for prediction of cancer progression and survival.

Need the full FDA record for Veridex, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K113181. Report a data issue: hello@regdatalab.com.